Gimv
Overview
Gimv is a European investment company, listed on Euronext Brussels. As a recognized market leader, they partner with entrepreneurial and innovative companies in 5 forward-looking investment areas. Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv's five investment platforms are Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities. They are a strategic partner for ambitious companies wanting to grow into leaders in their sectors. Gimv takes a flexible approach based on a solid balance sheet, patient capital and long-term view.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Exciva GmbH | Jan 2026 | Series B | Lead |
| Kinaset Therapeutics | Jan 2026 | Series B | Co-investor |
| Alpine Hearing Protection | Jun 2025 | Buyout/LBO | Lead |
| FIRE1 | Jan 2025 | Series B | Co-investor |
| Kivu Biosciences | Oct 2024 | Series A | Co-investor |
Key People
Bart Troubleyn
Managing Partner At Gimv Head Anchor Investments
Bram Vanparys
Managing Partner-Head Of Life Sciences
Koen Bouckaert
Managing Partner - Gimv Consumer Member Of The Executive Team And Investment Committee
Andreas Jurgeit
Partner
David De Peuter
Partner
Gautier Lefebvre
Partner - Healthcare
Guillaume Bardy
Partner
Maja Markovic
Partner
Michaël Vlemmix
Partner - Life Sciences
Patrick Franken
Partner At Gimv Consumer Private Equity
Philipp von Hammerstein
Partner
Ronald Bartel
Partner Smart Industries
Ruben Monballieu
Partner
Catharina Soenen
Principal - Sustainable Cities
Ferdinand Becker
Principal
François-Xavier Rico
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
